Impact News +++ BlackBerry Stock is Gapping Higher After Earnings, Here′s Why (Barchart) +++ BLACKBERRY Aktie -3,10%

RESMED Aktie

>RESMED Aktienkurs

219.7 EUR -0.4% (Tradegate)

Ask: 219.9 EUR / 55 Stück

Bid: 219.8 EUR / 46 Stück

Tagesumsatz: 54 Stück

Realtime Kurs von 8 bis 22 Uhr!

RESMED Aktie über LYNX handeln

Intraday

1 Jahr

>RESMED Performance

1 Woche: +1,0%

1 Monat: +1,9%

3 Monate: +6,2%

6 Monate: -0,4%

1 Jahr: +28,7%

laufendes Jahr: -1,8%

>RESMED Aktie

Name:

RESMED INC. DL-,004

Land:

USA

Sektor:

Gesundheit

ISIN/ Wkn:

US7611521078 / 895878

Symbol/ Ticker:

RME (Frankfurt) / RMD (NYSE)

Kürzel:

FRA:RME, ETR:RME, RME:GR, NYSE:RMD

Index:

S&P500

Webseite:

https://investor.resmed.c..

Marktkapitalisierung:

32290 Mio. EUR

Umsatz:

4405.23 Mio. EUR

EBITDA:

1544.46 Mio. EUR

Gewinn je Aktie:

6.827 EUR

Schulden:

736.93 Mio. EUR

Liquide Mittel:

829.13 Mio. EUR

Umsatz-/ Gewinnwachstum:

7.9% / 21.5%

KGV/ KGV lG:

28 / 23.98

KUV/ KBV/ PEG:

7.33 / 6.59 / 1.48

Gewinnm./ Eigenkapitalr.:

26.15% / 25.81%

Dividende je Aktie:

1.954 EUR

Dividendenrendite/ -schätzung:

0.9% / 0.86%

Div. Historie:

08.05.25 - 0.46852€
13.02.25 - 0.51037€

>weitere anzeigen...

Insiderhandel:

4 Insider verkauften innerhalb der letzten 30 Tage Aktien im Wert von 3.651.611 USD.

Suchwörter:

RESMED

Letzte Datenerhebung:

25.06.25

>RESMED Eigentümer

Aktien: 146.63 Mio. St.

f.h. Aktien: 145.7 Mio. St.

Insider Eigner: 0.67%

Instit. Eigner: 65.25%

Leerverk. Aktien: 7.21%

>RESMED Peer Group

BOSTON SCIENTIFIC

DEXCOM

GRIFOLS A ADR

GRIFOLS B ADR

HCA

ILLUMINA

TELADOC

TILRAY

UNITED THERAPEUTICS

VIKING THERAPEUTICS

>RESMED Chart & Kurs - NYSE

>RESMED News

19.06.25 - 06:36	Is the ResMed share price still cheap? What the numbers say (Fool)
	Let's see what analysts are saying about this blue chip as it nears a 52-week high. The post Is the ResMed share price still cheap? What the numbers say appeared first on The Motley Fool Australia....

16.06.25 - 13:54	ResMed Stock: Is RMD Outperforming the Healthcare Sector? (Barchart)
	ResMed has notably outperformed the healthcare sector over the past year, and analysts remain somewhat optimistic about the stock's long-term prospects....

11.06.25 - 05:01	Insiderhandel: Chief Executive Officer verkauft Aktien von ResMed im Wert von 2011910 USD (Insiderkauf)
	Farrell, Michael J. - Vorstand - Tag der Transaktion: 2025-06-09...

11.06.25 - 01:36	ResMed: A Mixed Bag for Investors Amid Rising Competition (Fool)
	Um den gesamten Artikel unter fool.com zu lesen, klicken Sie bitte auf die Überschrift...

07.06.25 - 01:01	Insiderhandel: Aufsichtsrat verkauft Aktien von ResMed im Wert von 494640 USD (Insiderkauf)
	Farrell, Peter C. - Aufsichtsrat - Tag der Transaktion: 2025-06-04...

04.06.25 - 17:30	ResMed (RMD) is a Top-Ranked Growth Stock: Should You Buy? (Zacks)
	The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage....

04.06.25 - 07:12	Up more than 75% since October 2023 — are ResMed shares a buy, hold or sell? (Fool)
	ResMed shares have surged more than 75% since October 2023, but is it too late to buy? We break down the long-term thesis. The post Up more than 75% since October 2023 — are ResMed shares a buy, hold or sell? appeared first on The Motley Fool Australia....

04.06.25 - 05:01	Insiderhandel: Chief Financial Officer verkauft Aktien von ResMed im Wert von 243780 USD (Insiderkauf)
	Sandercock, Brett - Vorstand - Tag der Transaktion: 2025-06-02...

03.06.25 - 21:01	Insiderhandel: Global General Counsel verkauft Aktien von ResMed im Wert von 9995 USD (Insiderkauf)
	Rider, Michael J. - Vorstand - Tag der Transaktion: 2025-06-02...

27.05.25 - 20:01	Insiderhandel: Chief Financial Officer verkauft Aktien von ResMed im Wert von 891286 USD (Insiderkauf)
	Sandercock, Brett - Vorstand - Tag der Transaktion: 2025-05-22...

23.05.25 - 14:30	Is it Worth Retaining ResMed Stock in Your Portfolio Now? (Zacks)
	RMD gains on strong mask sales and digital health growth, but faces macro headwinds and fierce competition....

23.05.25 - 13:48	Are Wall Street Analysts Bullish on ResMed Stock? (Barchart)
	Although ResMed has outperformed the broader market over the past year, Wall Street analysts maintain a cautiously optimistic outlook on the stock's prospects....

22.05.25 - 18:01	Insiderhandel: Aufsichtsrat verkauft Aktien von ResMed im Wert von 486940 USD (Insiderkauf)
	De, Witte Jan - Aufsichtsrat - Tag der Transaktion: 2025-05-20...

21.05.25 - 01:48	Should you buy the dip in the ResMed share price? (Fool)
	Let's see what one leading broker is saying following yesterday's pullback. The post Should you buy the dip in the ResMed share price? appeared first on The Motley Fool Australia....

20.05.25 - 06:00	Down 5%: Whats going on with the ResMed share price? (Fool)
	Let's see what has spooked investors today and caused them to push the sell button. The post Down 5%: What's going on with the ResMed share price? appeared first on The Motley Fool Australia....

20.05.25 - 05:24	Why Kogan, Monash IVF, OFX, and ResMed shares are falling today (Fool)
	Why are these shares taking a tumble today? Let's find out. The post Why Kogan, Monash IVF, OFX, and ResMed shares are falling today appeared first on The Motley Fool Australia....

19.05.25 - 17:30	Here′s Why ResMed (RMD) is a Strong Growth Stock (Zacks)
	The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage....

15.05.25 - 15:03	Resmed Champions Sleep Health as The Official Sleep Partner of The Qatar Airways British & Irish Lions Tour to Australia 2025 (GlobeNewswire EN)
	SAN DIEGO and LONDON and DUBLIN and SYDNEY, May 15, 2025 (GLOBE NEWSWIRE) -- Resmed (NYSE: RMD, ASX: RMD), the leading health technology company focused on sleep, breathing, and care delivered in the home, has been named the Official Sleep Partner of the Qatar Airways British & Irish Lions Tour to Australia....

09.05.25 - 18:01	Insiderhandel: Chief Executive Officer verkauft Aktien von ResMed im Wert von 1948003 USD (Insiderkauf)
	Farrell, Michael J. - Vorstand - Tag der Transaktion: 2025-05-07...

09.05.25 - 02:01	Insiderhandel: Aufsichtsrat verkauft Aktien von ResMed im Wert von 484500 USD (Insiderkauf)
	Farrell, Peter C. - Aufsichtsrat - Tag der Transaktion: 2025-05-07...

>weitere News anzeigen...

>Impressum >Über uns >Datenschutz >Financial Data & Solutions

>Behalte deine Investments mit realtime Kursen & News im Blick. Finde neue spannende Aktien! Registriere Dich und werde Mitglied!

Zitat des Tages: Wer das Recht mit Füßen tritt, steht selten fest auf den Beinen. - Stanislaw Jerzy Lec

Partner: >Tradegate Börse | >Dukascopy | >Boersentreff- Partner

Börsentreff auf Facebook |

Börsentreff auf X |

Börsentreff auf Instagram